Kensey Nash Angio-Seal
This article was originally published in The Gray Sheet
Hemostatic puncture closure system includes sizes 6F and 8F following FDA market go-ahead for the smaller version, granted to marketing partner St. Jude Medical and announced March 9. The 6F device, which addresses the market for punctures created during diagnostic catheterization procedures, gives St. Jude and Kensey Nash access to approximately 70% of the 6.5 mil. procedures performed through a 6F or smaller puncture in the femoral artery, Kensey Nash notes. An immediate launch of the Kensey Nash-made device through St. Jude's Daig division is anticipated
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.